A detailed history of First Command Advisory Services, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, First Command Advisory Services, Inc. holds 1,602 shares of MRNA stock, worth $59,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,602
Previous 1,602 -0.0%
Holding current value
$59,033
Previous $190,000 43.68%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$101.21 - $166.61 $404 - $666
-4 Reduced 0.25%
1,602 $190,000
Q1 2024

May 02, 2024

BUY
$85.37 - $115.44 $341 - $461
4 Added 0.25%
1,606 $171,000
Q3 2023

Nov 08, 2023

BUY
$96.41 - $126.61 $154,448 - $202,829
1,602 New
1,602 $165,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track First Command Advisory Services, Inc. Portfolio

Follow First Command Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Advisory Services, Inc. with notifications on news.